Recommendations of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR)Diagnosis and Treatment of Bronchiectasis
References (51)
- et al.
Normativa del diagnóstico y el tratamiento de la afección respiratoria en la fibrosis quística
Arch Bronconeumol
(2001) - et al.
Antibióticos nebulizados en pacientes con fibrosis quística
Med Clin (Barc)
(2001) - et al.
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients
Clin Microbiol Infect
(2005) Chronic cough due to bronchiectasis. ACCP Evidence-based clinical practice guidelines
Chest
(2006)- et al.
Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency
Int Immunopharmacol
(2004) - et al.
Antibody production deficiency with normal IgG levels in bronchiectasis of unknown etiology
Chest
(2005) - et al.
Nocardiosis y bronquiectasias
¿Una asociación frecuente? Enferm Infecc Microbiol Clin
(2005) - et al.
Quality-of-life determinants in patients with clinically stable bronchiectasis
Chest
(2005) - et al.
Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis
Chest
(2006) - et al.
Inhaled steroids improve quality of life in patients with steady-state bronchiectasis
Resp Med
(2006)
Nonpharmacologic airway clearance therapies: ACCP evidence-based clinical practice guidelines
Chest
(2006)
Evidence for physical therapies (airway clearance and physical training) in cystic fibrosis: an overview of five Cochrane systematic reviews
Resp Med
(2006)
Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. hDNase study group
Chest
(1998)
International guidelines for the selection of lung transplant candidates: 2006 update – a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation
J Heart Lung Transplant
(2006)
Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health
Am J Respir Crit Care Med
(2007)
An investigation into causative factors in patients with bronchiectasis
Am J Respir Crit Care Med
(2000)
Prevalence and economic burden of bronchiectasis
Clin Pulm Med
(2005)
Guidelines for the management of adult lower respiratory tract infections
Eur Respir J
(2005)
An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations
Am J Respir Crit Care Med
(2006)
Bronchiectasis: comparison of preoperative thin section CT and pathologic findings in resected specimens
Radiology
(1995)
IgG subclass deficiencies associated with bronchiectasis
Am J Respir Crit Care Med
(1996)
Utility of the antibody response to a conjugated Haemophilus influenzae type b vaccine for diagnosis of primary humoral immunodeficiency
Am J Respir Crit Care Med
(2000)
Genotype-phenotype correlation for pulmonary function in cystic fibrosis
Thorax
(2005)
Primary ciliary dyskinesia. Diagnostic and phenotypic features
Am J Respir Crit Care Med
(2004)
Assessment of airway neutrophils by sputum colour: correlation with airways inflammation
Thorax
(2001)
Cited by (180)
What Have We Learned About Bronchiectasis From RIBRON (Spanish Bronchiectasis Registry)?
2023, Archivos de BronconeumologiaAdvances in Bronchiectasis Registries: The New Chinese Registry
2022, Archivos de BronconeumologiaDecrease in Readmissions after Hospitalisation for COPD Exacerbation through a Home Care Model
2022, Open Respiratory ArchivesCritical appraisal of international adult bronchiectasis guidelines using the AGREE II tool
2022, European Journal of Internal MedicineInhaled antibiotics for treatment of adults with non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis
2021, European Journal of Internal Medicine
Copyright © 2008 Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Published by Ediciones Doyma S.L. All rights reserved All rights reserved.